NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

電子處方 (e-Rx)的全球市場 - 成長,趨勢,及預測(2019年 - 2024年)

E-prescribing Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 390865
出版日期 內容資訊 英文 113 Pages
商品交期: 2-3個工作天內
價格
電子處方 (e-Rx)的全球市場 - 成長,趨勢,及預測(2019年 - 2024年) E-prescribing Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年08月01日內容資訊: 英文 113 Pages
簡介

電子處方(e-Rx) 市場在2019年∼2024年間預測將以約18.3%的年複合成長率擴大。

本報告提供全球電子處方市場(e-Rx) 的相關調查,市場概況和成長要素、阻礙因素,競爭情形,各零組件、系統類型、安裝方式、終端用戶、使用方式、地區的市場分析,主要企業的簡介等資訊彙整。

目錄

第1章 簡介

  • 研究成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 處方錯誤的最小化
    • 電子處方系統的需求增加
    • 醫療品質的提高和降低成本
  • 市場阻礙因素
    • 電子處方系統的巨大成本
    • 處理系統的熟練人員不足
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各零件
    • 硬體設備
    • 軟體
    • 服務內容
  • 系統的種類
    • 獨立式
    • 整合型
  • 各安裝模式
    • 雲端基礎
    • Web為基礎
    • 內部部署
  • 各終端用戶
    • 醫院
    • 診療所
  • 各使用模式
    • 手機設備
    • 電腦為基礎的設備
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Allscripts Healthcare Solutions Inc.
    • Aprima Medical Software
    • Athenahealth Inc.
    • Cerner Corporation
    • DrFirst
    • eClinicalWorks
    • HealthFusion, Inc.
    • Relayhealth Corporation
    • Surescripts

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 52231

The E-prescribing Market is estimated to register a CAGR of about 18.8% over the forecast period.

  • Medical prescriptions are the written instructions by which physicians recommend and authorize the patients for purchasing and using prescription medicines and treatments.
  • Errors in prescription can creep in due to a variety of reasons, like the pharmacist's lack of knowledge and skill, and miscommunication between nurses and doctors, among others.
  • Among medication errors, prescription errors are one of the major causes of concern for healthcare professionals, globally. Moreover, according to the General Medical Council (GMC) 2018 report, in the United kingdom, prescribing errors and faults were reported in about 9%-15% of medication orders for hospital inpatients.
  • Although they are rarely fatal, they can have adverse effects on the patient's health and disease management. In addition to being a threat to the patient's wellbeing, prescription errors are the common cause of legal and medical malpractice claims against doctors and healthcare professionals.
  • At the time of prescribing, the e-prescribing systems can further decrease the errors by implementing alert and warning systems in addition to providing the patients with a complete background medical history.

Key Market Trends

Stand-alone E-prescribing System Segment is Expected to Hold a Major Market Share in the E-prescribing Market

  • The stand-alone e-prescribing system is an independent single entity system used for e-prescribing drugs to patients.
  • This system runs on software that acts a single mode, through which doctors or physician prescribe drugs to patients on an electronic platform.
  • Stand-alone e-prescribing applications are cheaper and easier to install than integrated systems. However, stand-alone applications may not have all of the functionality you will find in an e-prescribing module that is linked to an EMR.
  • Stand-alone applications may require the double entry of any clinical data. This requires additional work and risks of additional errors increases, thus slowing down the entire process.
  • Applications of the stand-alone systems are slowly being phased out from the healthcare IT sector as they are being replaced by integrated ones, which are more efficient and effective.
  • According to the Cittadinanzattiva survey report, in Italy about 57.5% of malpractice was caused by presumed mistakes during treatments in 2017.
  • The stand-alone system does not hold historical data of the patient and hence, sometimes follow up prescription may not be appropriate.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. In the North America region, the United States holds the largest market share which is mainly due to the government initiatives and incentive programs to promote the E-prescribing system, and rising demand for E-prescribing system in the United States. For instance, as per the SUPPORT for Patients and Communities Act, which the United State Congress passed in 2018, requires use of e-prescription for all the controlled substances, is to be under Medicare Part D by Jan 2021.

Competitive Landscape

The E-prescribing Market is consolidated competitive and consists of a few major players. In terms of market share, very few of the major players currently dominate the market. With the rising patient awareness levels, minimization of prescription errors, the better quality of health care and cost reduction, the companies are trying to innovate more products to sustain the competition. Some of the major players in the market are Cerner Corporation, NextGen Healthcare, Inc., eClinicalWorks, Veradigm (Allscripts Healthcare Solutions Inc), and eMDs, Inc are, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Minimisation of Prescription Errors
    • 4.2.2 Rising Demand for E-prescription System
    • 4.2.3 Better Quality of Healthcare and Cost Reduction
  • 4.3 Market Restraints
    • 4.3.1 Security and Workflow Issues
    • 4.3.2 Lack of Skilled Personnel to Handle the Systems
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Component
    • 5.1.1 Hardware
    • 5.1.2 Software
    • 5.1.3 Services
  • 5.2 By Type of System
    • 5.2.1 Stand-alone E-prescribing System
    • 5.2.2 Integrated E-prescribing System
  • 5.3 By Delivery Mode
    • 5.3.1 Cloud Based
    • 5.3.2 Web Based
    • 5.3.3 On-Premise
  • 5.4 By End Users
    • 5.4.1 Hospitals
    • 5.4.2 Clinics
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Veradigm (Allscripts Healthcare Solutions Inc)
    • 6.1.2 NextGen Healthcare, Inc
    • 6.1.3 Athenahealth Inc.
    • 6.1.4 Cerner Corporation
    • 6.1.5 DrFirst
    • 6.1.6 eClinicalWorks
    • 6.1.7 eMDs, Inc
    • 6.1.8 Relayhealth Corporation
    • 6.1.9 Surescripts

7 MARKET OPPORTUNITIES AND FUTURE TRENDS